InfuSystem Holdings Inc
NYSE-MKT:INFU
InfuSystem Holdings Inc
NYSE-MKT:INFU
Price:
7.51 USD
5.03%
Market Closed
Updated:
May 29, 2024
InfuSystem Holdings Inc
Revenue
|
InfuSystem Holdings Inc
Revenue Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
InfuSystem Holdings Inc
NYSE-MKT:INFU
|
Revenue
$127.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
|
|
DaVita Inc
NYSE:DVA
|
Revenue
$12.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
0%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Revenue
$9.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
CVS Health Corp
NYSE:CVS
|
Revenue
$360.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Cigna Corp
NYSE:CI
|
Revenue
$206B
|
CAGR 3-Years
8%
|
CAGR 5-Years
22%
|
CAGR 10-Years
20%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Revenue
$12.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
InfuSystem Holdings Inc
Revenue Breakdown
Breakdown by Geography
InfuSystem Holdings Inc
InfuSystem Holdings Inc
Not Available
Breakdown by Segments
InfuSystem Holdings Inc
InfuSystem Holdings Inc
|
Total Revenue:
125.8m
USD
|
|
Patient Services:
76.5m
USD
|
|
Device Solutions:
55.8m
USD
|
See Also
What is InfuSystem Holdings Inc's Revenue?
Revenue
127.4m
USD
127.4m
USD
Based on the financial report for Mar 31, 2024, InfuSystem Holdings Inc's Revenue amounts to 127.4m USD.
What is InfuSystem Holdings Inc's Revenue growth rate?
Revenue CAGR 10Y
7%
7%
Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for InfuSystem Holdings Inc have been 8% over the past three years , 13% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet
